Bio-Rad Laboratories | BIO - Ebitda

Preço das Ações
275.01
Mudança Diária
27.48 11.10%
Mensal
-9.34%
Anual
10.81%
Q2 Previsão
242.55




Ebitda Alterar Data
Abbott USD 3.27B 178M 2025-12
Agilent USD 540M 74M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio Techne USD 116.71M 13.29M 2026-03
Bio-Rad Laboratories USD 983.8M 1.36B 2025-12
Bruker USD 110M 101.6M 2026-03
Charles River Laboratories USD 229.8M 28.26M 2026-03
Danaher USD 1.92B 204M 2026-03
General Electric Aerospace USD 2.84B 568M 2026-03
Illumina USD 469M 137M 2025-12
IQVIA Holdings USD 932M 114M 2026-03
Laboratory Of America USD 605.6M 17.5M 2026-03
Merck USD 6.3B 2.09B 2025-12
Mettler Toledo International USD 278.99M 100.24M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quest Diagnostics USD 557M 20M 2026-03
Repligen USD 40.01M 469K 2026-03
Revvity USD 272.91M 24M 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
Siemens EUR 3.56B 80M 2026-03
Standard Biotools USD -15.81M 734K 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Tosoh JPY 39.13B 286M 2024-12
Waters USD 380.97M 85.83M 2025-12